ARE THE COSTS OF OUTPATIENT INTERMITTENT INOTROPIC THERAPY IN SEVERE HEART-FAILURE JUSTIFIED - A RANDOMIZED CONTROLLED CLINICAL-TRIAL OF DOBUTAMINE AND MILRINONE

Citation
Mr. Mehra et al., ARE THE COSTS OF OUTPATIENT INTERMITTENT INOTROPIC THERAPY IN SEVERE HEART-FAILURE JUSTIFIED - A RANDOMIZED CONTROLLED CLINICAL-TRIAL OF DOBUTAMINE AND MILRINONE, Circulation, 96(8), 1997, pp. 1015-1015
Citations number
NO
Categorie Soggetti
Peripheal Vascular Diseas",Hematology
Journal title
ISSN journal
00097322
Volume
96
Issue
8
Year of publication
1997
Supplement
S
Pages
1015 - 1015
Database
ISI
SICI code
0009-7322(1997)96:8<1015:ATCOOI>2.0.ZU;2-X